To investigate how cytotoxic T lymphocytes (CTL) avoid killing themselves when they destroy target cells, we compared 20 different cell lines as target cells, including several CTL cell lines, for their susceptibility to lysis by CTL.
Variations in recognition of this diverse set of target cells was circumvented by attaching to all ofthem a monoclonal antibody to the antigen-specific receptor of a cloned CTL cell line (done 2C) and using the 2C cell line as the standard aggressor or effector cell. All of the nine tumor cell lines and the four noncytolytic T-helper cell lines tested as targets were highly susceptible to lysis by the aggressor CTL, but seven cytotoxic T-cell lines (six CTL and one T-helper cell line with cytotoxic activity) were largely resistant. These results, and the use of the lectin Con A as an alternative means for triggering CTL activity, point clearly to a level of resistance that could enable CTL to avoid their own destruction when they lyse target cells. The resistance of the cytolytic T cells did not appear to be accompanied by a similar resistance to complement-mediated lysis, indicating that mechanisms of CTL-mediated and complement-mediated lysis are not identical.
Cells that have evolved mechanisms for killing other cells can reasonably be expected to have also developed mechanisms to avoid killing themselves. This generalization seems to apply to the cytotoxic T lymphocytes (CTL) that play a major role in immune defenses of vertebrates against viral and perhaps other infectious agents (e.g., see ref. 1) . When a CTL adheres to a target cell whose surface antigen it recognizes, the CTL is stimulated to release cytolytic components that cause the adherent target cell to undergo lysis (reviewed in refs. 2 and 3). However, the CTL itself is evidently undamaged, since it can carry out the process repetitively, migrating from one target cell to another, lysing each in turn (4, 27) . The destruction of only the target cell could mean that the plasma membrane of a CTL is resistant to the cytolytic components it releases. However, some evidence suggests that, under certain circumstances, a CTL can be destroyed if it is recognized by another CTL (4-7) as though a CTL, when recognized, is no more resistant than other target cells. The latter evidence for one-way killing, resulting from one-way recognition, could mean that the cytolytic components released by an aggressor CTL (activated by antigen recognition) are so directed that they impinge only on the membrane of the recognized target cell (CTL or other) and not on the membrane of the aggressor cell itself. However, it is also possible that cytolytic components impinge on both the aggressor and the target cell but that the aggressor CTL is largely resistant to these components, perhaps only transiently while it attacks a target cell or perhaps only locally at the site of CTL-target cell contact.
To evaluate these possibilities, we have here compared the susceptibility ofdiverse cell lines, including CTL, to cytolytic attack by CTL. Since cytolytic activity is normally triggered by a CTL's recognition of antigen on a target cell, and most of the 20 cell lines tested as targets had different surface antigens, we sought to standardize their recognition through the use of a monoclonal antibody (mAb) to the antigenspecific receptor of a cloned CTL cell line (clone 2C). As we showed previously, this antibody (mAb 1B2) can simulate the antigen that is normally recognized by clone 2C; thus, when the 1B2 antibody was attached to the surface of several different tumor cell lines that lacked the natural antigen of the 2C cell (Ld, a class I glycoprotein encoded by the major histocompatibility complex) the 1B2-modified cells were all lysed specifically by 2C cells (8) .
In the present study, we accordingly attached mAb 1B2 to a panel of cloned CTL and various other cell lines and compared their susceptibility to lysis by CTL clone 2C. We found that, although all of the nine tumor cell lines and four noncytolytic T-cell lines examined in this way were effectively lysed by the CTL clone, seven cytolytic T cell lines (six CTL and one T-helper cell with cytolytic activity) were all clearly resistant to lysis. Nevertheless, the resistant CTL were as effective as the susceptible cells in inducing 2C cells to discharge their cytolytic granules, as indicated by the secretion of a serine esterase that is associated with these granules (19) . The findings suggest that at least one mechanism that enables CTL to avoid their own destruction when they kill other cells is their resistance to the cytolytic components they release.* MATERIALS AND METHODS Cell Lines. Mouse tumor cell lines, P815 (H-2d), EL4 (H-2b), BW5147 (H-2k), S49 (H-2d), R1.1 (H-2k), and mouse L cells transfected with Dd (cell line T4.83) were maintained in culture with RPMI 1640 medium as described (9) .
Cloned CTL lines 2C (anti-Ld) (9), 2.1.1 (anti-Ld) (8), G4 (anti-Dd) (10), 3C11 (anti-Dd) (11), 4K3 (anti-Ld) (11) , and 3 (anti-Dd) (12) and cloned T-helper cell lines TH-1 (antitrinitrophenyl/H-2d) (G. Sigal, personal communication), 18.1 (anti-H-2b) (13) , 5-5 (anti-ovalbumin/H-2d) (14) , and D10 (anti-conalbumin/H-2k) (15) T-cell receptor of clone 2C and its purification have been described (8 Fig.  2, the resistant 1B2-modified 2.1.1 cells (i.e., lB2-2.1.1 ) and the susceptible 1B2-EL4 cells were equally effective as specific inhibitors and were thus equally well recognized by the cytolytic 2C cells.
To determine whether the resistant CTL targets actually stimulated the aggressor CTL's release of cytolytic components, we took advantage of a previous finding that when a CTL recognizes and attacks a target cell it releases cytotoxic granules that contain a cytolytic protein, termed perforin (20, 21) , -and also a serine esterase (19) ; the latter is readily measured in the culture medium by a sensitive chromogeneic assay (see Materials and Methods). Table 2 although the 2C cells did not cause the 51Cr-labeled 1B2-targeted CTL to release 51Cr, they might have damaged the targeted CTL to the point where their cytolytic activity was substantially lost. To test this possibility, we examined a 1B2-modified CTL line (G4) whose specificity (anti-Dd) differed from that of the aggressor CTL (2C cells, which are anti-Ld). After incubating 1B2-G4 cells together with 2C cells for 4 hr, 51Cr-labeled target cells for clone G4 (L cells transfected with Dd) were added to assess the remaining cytotoxic activity of the 1B2-G4 cells. As shown in Table 3 , there was absolutely no decrease in the cytotoxic activity of the 1B2-modified G4 cells as compared to unmodified G4 cells or to 1B2-modified G4 cells that had not been exposed to the aggressor 2C cells. Thus, in addition to not lysing G4 cells, CTL clone 2C had no detectable effect on the cytolytic activity of the G4 cell line.
CTL Are Not Uniformly Resistant to All Other CTL. In post previous studies in which one set of CTL appeared to'have been inactivated by other CTL, the aggressor CTL were contained in heterogeneous spleen cell populations [mixed lymphocyte cultures (MLC)] that had been stimulated by an allogeneic class I major histocompatibility complex-encoded antigen (4-6). Fig. 3A shows the effect ofa MLC [from spleen cells of BALB.K (H-2k) mice that had been stimulated by spleen cells from BALB.B (H-2b) mice] on various 51Cr-labeled CTL with the H-2b haplotype, including 2C and two other CTL (G4 and 2.1.1) that were resistant to lysis by clone 2C. All three ofthe 51Cr-labeled H-2b CTL were clearly lysed, although it required 3-10 times more MLC cells to lyse them to the same extent as the standard EL4 lymphoma cells. In considering these results, it is important to realize that a MLC contains diverse cytotoxic cells. Hence, the lysed target CTL (2.1.1, G4, 2C) might have been subjected to the combined attack of various aggressor cells, including CTL that were specific for diverse H-2b epitopes on the target CTL and also perhaps by activated macrophages; the latter are cytotoxic not by virtue of pore-forming activity but rather by release of reactive, oxygen intermediates.
To explore further the extent to which diverse CTL cell lines can serve as effective targets for other CTL, we took advantage of the well-known ability of the lectin Con A to activate CTL so that they will lyse cells to which they are adherent, regardless of the CTL's own specificity or the antigens on the prospective target cells. Three cloned CTL cell lines were tested for their ability in the presence of Con A to lyse various 51Cr-labeled CTL and EL4 lymphoma cells.
As shown in Fig. 3 and various concentrations of guinea pig serum (GPS) complement.
After 3 hr at 370C, supernatants were assayed for radioactivity. The density ofThy-1 on the surface ofthese cells and the other cells tested (Table 1) were shown by fluorescence-activated cell sorter analysis to be nearly identical (data not shown).
a source of complement) were added to the cells. Representative titrations are illustrated in Fig. 4 and all results are summarized in, Table 1 by listing the amount of complement required to lyse the cell lines to the same extent (33%). There was only a limited correlation between susceptibility to lysis by complement and by CTL. For example, a cloned T-helper cell line (18.1) that was highly susceptible to lysis by CTL clone 2C required as much complement as did three CTL lines (4K3, 2C, and 3) that were all resistant to lysis by CTL clone 2C. However, the two CTL clones that were most resistant to complement (2.1.1 and G4) were also the most resistant to lysis by CTL clone 2C. Hence, these two clones might share a mechanism, such as the efficient clearance of channels or pores from cell membranes, that may account for the decreased susceptibility of some nucleated cells to lysis by complement (22) . However, the lack of a strict correlation between susceptibility to lysis by CTL and complement suggests that there are significant differences between these two mechanisms for destroying antigen-bearing cells (as previously proposed, see ref. 24 ).
DISCUSSION
The destruction of a target cell by a CTL is the end result of a reaction sequence that begins with the formation of a CTL-target cell conjugate. In such a conjugate the CTL, activated via its receptor's recognition of antigen on the target cell, releases the contents of cytotoxic granules at the CTL-target cell junction (19, 20) . One of the released components, perforin, resembles complement factor nine (C9) and appears, like C9, to lyse target cells by forming transmembrane channels in target cell membranes (21, 23) . If perforin reacts in the same way with CTL membranes, how does a CTL avoid killing itself when it kills a target cell?
The evidence presented here suggests that the answer, at least in part, is that CTL are largely resistant to the effects of the cytolytic components released by activated CTV. Our most direct evidence derives from observations with a mAb (1B2) to the antigen-specific receptor of a cloned CTL line (clone 2C). When attached to diverse cells this antibody, acting as an antigen substitute, renders the "1B2-modified" cells susceptible to lysis by 2C cells. Altogether, we have now examined 24 1B2-modified cell lines, including 9 tumor cell Proc. Natl Acad Sci. USA 84 (1987) lines (of human and mouse origin), 5 noncytolytic T-cell hybridomas, 4 cloned mouse T-cell lines (D10, 5-5, TH-1, 18.1) with the helper phenotype (CD4',CD8-), and 7 mouse T-cell clones (CTLL, 3C11, 4K3, G4, 2.1.1, 2C, 3) with the CTL phenotype (CD4-,CD8+). The susceptibility of these cell lines to lysis by CTL clone 2C correlated consistently with their own cytolytic capacity-i.e., the cytotoxic cell lines were more resistant to lysis than the noncytolytic cell lines (Table 1) .
These results are supported by a recent observation that CTL specific for a peptide from the nucleoprotein of influenza virus can kill target cells, but not themselves, in the presence of added peptide (25) . Other evidence that CTL are spared from self-killing was provided iii another study using the lectin Con A to mediate CTL-target cell interaction (26) . In the latter study, as in the results shown here with lectiti-mediated killing (Fig. 3) , not all CTL were resistant to the lethal effects of all other CTL. The results suggest that a targeted CTL may be highly resistant to some CTL and less resistant to others, as though effector CTL vary in their aggressiveness (e.g., the amount of cytolytic components released). This variability may account for the many reports that show CTL are susceptible to lysis by alloreactive mixed lymphocyte populations (4-6; see also Fig. 3A ) and the occasional observation that one CTL Qlone can kill another CTL clone (7) .
It is widely believed that CTL kill target cells by a unidirectional process, as though CTL, when activated by recognition of targets, eject cytotoxic granules toward the adherent target and away from the CTL surface. Our results do not rule out such a process. But they do establish that CTL, unlike the other cells tested, have unusual resistance to their released toxic components. This conclusion is supported by preliminary efforts using isolated cytotoxic granules to examine a wide array of eukaryotic cells for susceptibility to lysis (R. Verret, A. Firmenich, D.M.K., and H.N.E., unpublished data).
